HAYWARD,
Calif., July 27, 2023 /PRNewswire/ -- AcelRx
Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty
pharmaceutical company focused on the development and
commercialization of innovative therapies for use in medically
supervised settings, today announced that it will release second
quarter 2023 financial results after market close on Thursday, August 10, 2023, then host a live
webcast and conference call at 4:30 p.m.
Eastern Daylight Time/1:30 p.m.
Pacific Daylight Time to discuss the results and provide an
update on the Company's business.
Webcast Information
The webcast can be accessed here or by visiting the Investors
section of the Company's website at www.acelrx.com and clicking on
the webcast link within News & Events/Upcoming Events
section. The webcast will include a slide presentation and a
replay will be available on the AcelRx website for 90 days
following the event.
Conference Call Information
Investors who wish to participate in the conference call may do
so by dialing 1-866-361-2335 for domestic callers, 1-855-669-9657
for Canadian callers, or 1-412-902-4204 (toll applies) for
international callers. The conference ID is 10181172.
About AcelRx Pharmaceuticals, Inc.
AcelRx
Pharmaceuticals, Inc. is a specialty pharmaceutical company focused
on the development and commercialization of innovative therapies
for use in medically supervised settings. AcelRx's lead product
candidate, Niyad is a lyophilized formulation of nafamostat and is
currently being studied under an investigational device exemption,
or IDE, as an anticoagulant for the extracorporeal circuit, and has
received Breakthrough Device Designation Status from the FDA.
AcelRx is also developing two pre-filled syringes in-licensed from
its partner Aguettant: Fedsyra™, a pre-filled ephedrine syringe,
with an expected NDA filing in 2023, and PFS-02, a pre-filled
phenylephrine syringe with an expected NDA filing in 2024. This
release is intended for investors only. For additional information
about AcelRx, please visit www.acelrx.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/acelrx-to-host-second-quarter-2023-financial-results-call-and-webcast-on-august-10-2023-301887209.html
SOURCE AcelRx Pharmaceuticals, Inc.
